02315.HK
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 61.25
+0.25%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 62.74x
- P/E 2027E
- 39.04x
- P/E 2028E
- 24.88x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 61.63x
- PEG TTM
- —
- Price / book
- 8.66x
- Price / sales
- 12.33x
- Price / cash flow
- 50.98x
Enterprise value
- Enterprise value
- HKD 24.3B
- EV / sales
- 12.23x
- EV / EBITDA
- 35.54x
- EV / EBIT
- 47.10x
- Market cap
- HKD 24.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026